{
    "id": "NCLEXRN_NGN_ORDRESP_001",
    "itemType": "orderedResponse",
    "question": {
        "stem": "The nurse is caring for a 32-year-old G1P0 client at 34 weeks gestation admitted for management of severe preeclampsia. The client, who had limited prenatal care due to transportation barriers, is receiving a magnesium sulfate infusion. The nurse reviews the most recent data in the electronic health record (EHR). Based on this new information, which actions should the nurse take? Arrange the actions in the correct order of priority.",
        "prompt": "Arrange the actions in the appropriate order from first to last.",
        "tabs": [
            {
                "id": "tab1",
                "label": "Nurses' Notes",
                "content": "**0900:** Client reports a persistent frontal headache, rated 6/10, unrelieved by acetaminophen. States she is seeing 'spots' and feels nauseated. Also reports new-onset, severe epigastric pain radiating to her right upper quadrant, describing it as a 'deep, constant ache'. Deep tendon reflexes are +3 with 2 beats of clonus. Client appears anxious and restless."
            },
            {
                "id": "tab2",
                "label": "Vital Signs",
                "content": [
                    {
                        "time": "0600",
                        "BP": "162/108 mmHg",
                        "HR": "88 bpm",
                        "RR": "18/min",
                        "Temp": "37.1°C (98.8°F)",
                        "SpO2": "98% on room air"
                    },
                    {
                        "time": "0800",
                        "BP": "168/112 mmHg",
                        "HR": "92 bpm",
                        "RR": "20/min",
                        "Temp": "37.2°C (99.0°F)",
                        "SpO2": "97% on room air"
                    },
                    {
                        "time": "0930",
                        "BP": "174/116 mmHg",
                        "HR": "96 bpm",
                        "RR": "22/min",
                        "Temp": "37.2°C (99.0°F)",
                        "SpO2": "96% on room air"
                    }
                ]
            },
            {
                "id": "tab3",
                "label": "Laboratory Results",
                "content": [
                    {
                        "lab": "Platelet Count",
                        "value": "45,000/mm³",
                        "reference": "150,000-400,000/mm³"
                    },
                    {
                        "lab": "Aspartate Aminotransferase (AST)",
                        "value": "820 U/L",
                        "reference": "10-40 U/L"
                    },
                    {
                        "lab": "Alanine Aminotransferase (ALT)",
                        "value": "750 U/L",
                        "reference": "7-56 U/L"
                    },
                    {
                        "lab": "Hemoglobin",
                        "value": "9.8 g/dL",
                        "reference": "12.0-16.0 g/dL"
                    },
                    {
                        "lab": "Serum Creatinine",
                        "value": "1.3 mg/dL",
                        "reference": "0.6-1.2 mg/dL"
                    }
                ]
            },
            {
                "id": "tab4",
                "label": "Diagnostic Data",
                "content": "**Continuous Fetal Monitoring Strip Interpretation (Current):**\nBaseline Fetal Heart Rate (FHR): 105 bpm\nVariability: Minimal to absent\nAccelerations: Absent\nDecelerations: Recurrent late decelerations noted with each contraction.\nInterpretation: Category III Fetal Heart Rate Tracing"
            },
            {
                "id": "tab5",
                "label": "MAR",
                "content": [
                    {
                        "medication": "Magnesium Sulfate IV",
                        "dose": "2 g/hr continuous infusion",
                        "status": "Infusing"
                    },
                    {
                        "medication": "Labetalol IV Push",
                        "dose": "20 mg over 2 minutes",
                        "status": "Administered at 0815"
                    },
                    {
                        "medication": "Anesthesia Consult for Epidural Placement",
                        "dose": "STAT",
                        "status": "Ordered, awaiting anesthesia arrival"
                    }
                ]
            }
        ],
        "options": [
            {
                "id": "opt1",
                "content": "Prepare the client for an emergency cesarean delivery."
            },
            {
                "id": "opt2",
                "content": "Request a STAT page for the obstetrician and neonatologist."
            },
            {
                "id": "opt3",
                "content": "Initiate intrauterine resuscitation measures."
            },
            {
                "id": "opt4",
                "content": "Notify the anesthesia provider of the platelet count and cancel the epidural placement."
            }
        ]
    },
    "answer": [
        "opt4",
        "opt3",
        "opt2",
        "opt1"
    ],
    "rationale": {
        "correct": "The client's clinical presentation has rapidly deteriorated from severe preeclampsia to HELLP (Hemolysis, Elevated Liver enzymes, Low Platelets) syndrome, accompanied by severe fetal compromise. The correct sequence of actions prioritizes preventing immediate iatrogenic harm, stabilizing the fetus, communicating critical changes, and preparing for the definitive treatment (delivery).\n\n1. **Cancel Epidural:** This is the critical first 'SAFETY STOP' action. The platelet count of 45,000/mm³ is a severe thrombocytopenia and an absolute contraindication for neuraxial anesthesia (epidural/spinal). Proceeding would pose a high risk of an epidural hematoma, leading to spinal cord compression and permanent paralysis. Preventing this catastrophic harm is the immediate priority.\n2. **Intrauterine Resuscitation:** The Category III fetal heart rate tracing indicates severe fetal acidemia and impending death. Immediate intrauterine resuscitation (e.g., left-lateral positioning, 10 L/min O2 via non-rebreather mask, IV fluid bolus) is required to improve uteroplacental perfusion and fetal oxygenation while preparing for delivery.\n3. **Notify Providers:** After taking immediate safety and resuscitation actions, the nurse must urgently communicate the full clinical picture (critical labs, Category III tracing, maternal instability) to the obstetrician and ensure the neonatal team is aware and prepared for a compromised newborn.\n4. **Prepare for Emergency C-section:** With both maternal (HELLP syndrome, risk of liver rupture/stroke) and fetal (Category III tracing) decompensation, delivery is the only definitive treatment and must be expedited. This is the ultimate goal, but it can only proceed after the preceding safety and communication steps are completed.",
        "answerBreakdown": [
            {
                "label": "1",
                "content": "Notify the anesthesia provider of the platelet count and cancel the epidural placement.",
                "isCorrect": true,
                "justification": "This is the highest priority. Severe thrombocytopenia (platelets < 50,000/mm³) is an absolute contraindication to epidural placement due to the life-altering risk of epidural hematoma. The nurse MUST recognize this critical lab value and act independently to stop an unsafe procedure before it occurs. This is a classic 'Don't Proceed' safety intervention."
            },
            {
                "label": "2",
                "content": "Initiate intrauterine resuscitation measures.",
                "isCorrect": true,
                "justification": "This is the second priority. The Category III fetal heart tracing (bradycardia, absent variability, late decelerations) is an obstetrical emergency indicating severe uteroplacental insufficiency and fetal hypoxia. The nurse must immediately intervene to improve fetal oxygenation (e.g., repositioning, oxygen, IV fluids) while awaiting definitive treatment."
            },
            {
                "label": "3",
                "content": "Request a STAT page for the obstetrician and neonatologist.",
                "isCorrect": true,
                "justification": "This is the third priority. After preventing iatrogenic harm and starting resuscitation, the nurse must communicate the critical data to the interprofessional team to facilitate rapid decision-making for an emergency delivery. The situation requires immediate physician intervention for both mother and fetus."
            },
            {
                "label": "4",
                "content": "Prepare the client for an emergency cesarean delivery.",
                "isCorrect": true,
                "justification": "This is the fourth priority. Delivery is the only definitive cure for HELLP syndrome and is urgently indicated by the maternal and fetal deterioration. This action involves preparing the patient, ensuring consents are in place (if possible), and coordinating with the surgical team. It is the end goal of the preceding life-saving actions."
            }
        ]
    },
    "pedagogy": {
        "bloomLevel": "Analyzing",
        "cjmmStep": "Take Actions",
        "nclexCategory": "Reduction of Risk Potential",
        "difficulty": "Level 4-5",
        "topicTags": [
            "HELLP Syndrome",
            "Preeclampsia",
            "Fetal Distress",
            "Thrombocytopenia",
            "Medication Safety",
            "Contraindication",
            "High-Risk Obstetrics"
        ]
    }
}